Navigation Links
Shamir Optical Industry Ltd. Reports Third Quarter 2008 Results
Date:11/26/2008

n of GAAP operating income and net income to non-GAAP operating income and non-GAAP net income is set forth below.

As of September 30, 2008, the Company had cash and cash equivalents, including short-term investments of $25.1 million.

Commenting on the results, Eyal Hayardeny, Chief Executive Officer of Shamir, said, "Shamir preformed well in the third quarter, particularly in light of an increasingly difficult economic environment throughout the world. We executed solidly and continued to make important inroads in many of our operating markets, with the goal of advancing the recognition for Shamir-branded products. Concurrent with these efforts, we continue to stress the importance of strict cost controls, which has always been a main component of our operating philosophy, but has become increasingly important during these difficult economic times."

Mr. Hayardeny continued, "With Altra coming under full ownership and operational control of Shamir during the quarter, we further advanced our European distribution network. In addition, we are now in a position to exact greater operational and cost efficiencies throughout our European operations. With the team we currently have in place, we are confident that we can continue to expand our footprint throughout the region and in turn gain strong returns on this investment."

Mr. Hayardeny concluded, "With the widening of the economic difficulties throughout the world, it has become increasingly difficult to forecast our sales. With that said, we still believe we will be able to meet previously announced forecasts of estimate for growth in the range of 10%-16%, based on the December 2007 exchange rates and excluding the results of our Mexican operation."

Conference Call:

Shamir has scheduled a conference call for 11:00 a.m. ET today to discuss third quarter results. To participate i
'/>"/>

SOURCE Shamir Optical Industry Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results
2. Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results
3. Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2007 Results
4. Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results
5. Shamir Optical Industry Ltd. Reports First Quarter 2008 Results
6. Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH
7. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
8. Optical scientist honored for understanding and improving vision
9. Minority patients prefer optical colonoscopy for colorectal cancer screening
10. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
11. Optical Coherence Tomography Market to Top $800 Million by 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... After working diligently for months and putting ... announced the integration of the fitment specs for the redesigned ... to stun the automobile market with its extraordinary features and ... marked as the latest entry in the size it ... for the year 2013. , Aptly suiting its name, ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 During Better ... loss should consider the legal protections they have, including ... problems arise with their child’s treatment or hearing aid ... Since 1927, the American Speech-Language-Hearing Association has used the ... and to promote treatment, such as cochlear implants, which ...
(Date:5/18/2013)... Rosa, CA (PRWEB) May 18, 2013 ... . The simple to read reviews and comprehensive comparisons ... and impartial home security reviews. 6Webs.com just recently finished ... alarm system providers. , Tim Smythe from 6Webs.com reports, ... security systems due to their ease of use, expandability ...
(Date:5/18/2013)... Francisco, CA (PRWEB) May 18, 2013 ... appointments for 2013 therapies. At the Ayurvedic Spa ... guidance of panchakarma practitioner and lifestyle recommendations ... Ayurveda, the “knowledge of life", is the traditional healthcare ... that a life of harmony is the basis for ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Dr. Robert Tracey, ... apnea dentistry, employs his knowledge of the root causes ... apnea patients. With May being Better Sleep Month, Dr. Tracey ... sort of chronic sleep disorder, and sleep apnea is one ... apnea, a person will essentially stop breathing at different times ...
Breaking Medicine News(10 mins):Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3
... - Ansell Guardian(SM) Enables ... and Productivity , ... market,for hand protection solutions Frost & Sullivan, a global ... European Protective,Gloves Customer Service Leadership Award. The award is ...
... Disease in Washington, DC Area , , ... Kidney Foundation: , , WHO: ... Guests - 1,000 of the Washington area,s ... Special Guests - Alonzo Mourning, kidney transplant recipient, ...
... up to 30% of beneficial species, strains are significantly ... treatment, especially when prolonged or repeated, may have a ... gut, according to a new study. , Gut ... nutrition, metabolism and immune responses, experts note. , Researchers ...
... Changing Times,Vitamins, Inc., (Pink Sheets: SGTB) announced today ... Features Syndicate, Division of Hearst,Corporation, one of the ... Times Vitamins (CTV) the right to produce and ... Popeye(R) and associated characters for sale,and promotion of ...
... a wedding have over seven,online wedding guides to help them ... planning a funeral have none -- until now. The ... the Bay Area. , ... find vendors. Some,people will use our guide to find ...
... Nov. 19 Graeme Green Ph . D ... the results of the JUPITER study presented at the American Heart ... , The results of the 17,802-patient trial demonstrated AstraZeneca,s ... and death among patients who seemed healthy but showed high levels ...
Cached Medicine News:Health News:Ansell Healthcare Europe Lands 2008 Frost & Sullivan Customer Service Leadership Award for its Ansell Guardian(SM) Safety Program 2Health News:Special Guest Alonzo Mourning to Attend National Kidney Foundation's 28th Annual Kidney Ball Featuring Entertainment by the Doobie Brothers 2Health News:Long-Term Antibiotic Use Affects 'Good' Gut Bacteria 2Health News:King Features Syndicate and Changing Times Vitamins Sign Licensing Agreement for Popeye(R) the Sailor Man in the Water Drink Category. 2Health News:King Features Syndicate and Changing Times Vitamins Sign Licensing Agreement for Popeye(R) the Sailor Man in the Water Drink Category. 3Health News:Bagpipers and Dove Release - Hello BayAreaFuneralGuide.com! 2Health News:Bagpipers and Dove Release - Hello BayAreaFuneralGuide.com! 3Health News:Analyst Available to Comment on New JUPITER Study That Shows AstraZeneca's Crestor Significantly Reduces CV Risk 2
(Date:5/17/2013)... May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & General ... Conference on Thursday, May 30, 2013, in New ... The Company,s presentation is scheduled to begin at ... webcast. To access the webcast, go to www.atossagenetics.com . ...
(Date:5/16/2013)... and ZURICH , May 17, ... Agency for Science, Technology and Research (A*STAR) and ... first healthy volunteer has been dosed in a Phase 1 ... Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this ... this novel vaccine candidate and its potential to protect against ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... of data from more than 12,000 people with cystic fibrosis ... infection in the Cystic Fibrosis Foundation,s Patient Registry shows that ... associated with a 21% reduction in mortality in the following ... North American Cystic Fibrosis Conference (NACFC) in Baltimore, Maryland, sponsored ...
... Bionovo, Inc. (Nasdaq: BNVI ) today announced ... discussing new classes of estrogen receptor modulating drugs with ... in the most recent edition of Current Opinion ... Specific Target Genes and Biological Responses by Estrogen Receptor ...
Cached Medicine Technology:Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection 2Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection 3Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection 4Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection 5Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 2Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 3Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions 4
... simply and successfully, the Unistik 2 range ... offering a variety of needle gauges and ... requirements. ,All have the same unique single-use ... cross-infection, and a side firing action to ...
The Stat-Let lines of disposable lancets are all designed with the goals of providing a safe and easy to achieve capillary blood sampling. All of our lancets can be used by most current models of lan...
Lancets are the fine needles used with a lancing device to draw a blood sample for glucose testing. To make testing less painful, we developed lancets with extra-thin tips....
... screening test for determining the presence of ... system is considered the manual standard, authenticated ... system meets defined NCCLS/ICSH guidelines designed to ... are also available for pediatric applications, or ...
Medicine Products: